InNexus Biotechnology collaborates with the NCI

InNexus Biotechnology has announced that it has entered into a collaboration agreement with the National Cancer Institute to research antibody-based technologies developed by InNexus. InNexus has collaborations with XERIS Pharmaceuticals, Genhelix, Cephalon, Affimed and GlaxoSmithKline

About these ads

Leave a Comment

Filed under alliances

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Connecting to %s